Clinical Trial: A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged >=2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome

U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285005) titled 'A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged >=2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome' on Nov. 19.

Brief Summary: This is a phase 3, double-blind, randomized, placebo-controlled, parallel group, adaptive, multicenter study planned to be conducted at multiple sites in North America, Canada, Taiwan and South Korea.

The purpose of this study is to measure the efficacy and safety of KP-001 compared with placebo in patients aged >=2 years with common VM, common LM, or KTS/CLOVES syndrome.

An independent data monitoring committee (DMC) will be established to determine whe...